prolintane

Also Known As:

1-(alpha-propylphenethyl)pyrrolidine; Katovit; Promotil; phenylpyrrolidinylpentan; prolintane hydrochloride

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Fatigue 12/01/1966 - "A trial of prolintane in the treatment of fatigue." 12/01/1974 - "Prolintane in debility and fatigue. "
2.	Hallucinations (Hallucination) 09/01/2007 - "Overdoses of prolintane may cause hallucinations, psychosis, and death. " 01/01/2002 - "The case of a young man is presented who developed visual hallucinations following two months of concomitant use of prolintane and diphenhydramine at therapeutic dosages. " 01/01/2002 - "Visual hallucinations induced by the combination of prolintane and diphenhydramine." 01/01/2002 - "An increase in dopaminergic brain activity is proposed as the causal mechanism for hallucinations--whereas prolintane can induce the release of dopamine at the synaptic cleft, diphenhydramine can act inhibiting the reuptake of dopamine and inducing a potentiation of its effects. "
3.	Psychotic Disorders (Schizoaffective Disorder) 09/01/2007 - "Overdoses of prolintane may cause hallucinations, psychosis, and death. "
4.	Frailty 12/01/1974 - "Prolintane in debility and fatigue. "